Literature DB >> 8132663

Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA.

R D Prokipcak1, D J Herrick, J Ross.   

Abstract

The short half-life of c-myc mRNA is influenced by sequences in the 3'-untranslated region and the C-terminal part of the coding region. In cell-free extracts, a polysomal protein binds to RNA corresponding to the coding region stability determinant. This and other observations suggest that the protein is bound to polysome-associated c-myc mRNA and protects the mRNA from a ribosome-associated endoribonuclease (Bernstein, P.L., Herrick, D.J., Prokipcak, R.D., and Ross, J. (1992) Genes & Dev. 6, 642-654). Here, we describe a four-step purification of the binding protein: solubilization from ribosomes, ammonium sulfate precipitation, RNA affinity chromatography, and reverse-phase high performance liquid chromatography. The 70-kDa protein can be renatured from solutions containing sodium dodecyl sulfate or organic solvents, greatly facilitating its purification. Protein binding to c-myc coding region RNA is blocked by diamide and N-ethylmaleimide, indicating a requirement for sulfhydryl groups. The protein also binds to N-myc coding region RNA but with approximately 5-fold lower affinity than to the comparable c-myc region. Excess c-myc competitor RNA induces 8-fold destabilization of c-myc mRNA in cell-free mRNA decay extracts. In contrast, N-myc coding region competitor RNA has no effect on c-myc mRNA half-life. Therefore, the protein we have purified probably affects c-myc mRNA metabolism with high specificity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132663

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Identification of in vivo mRNA decay intermediates corresponding to sites of in vitro cleavage by polysomal ribonuclease 1.

Authors:  M N Hanson; D R Schoenberg
Journal:  J Biol Chem       Date:  2001-01-04       Impact factor: 5.157

2.  Vigilin binding selectively inhibits cleavage of the vitellogenin mRNA 3'-untranslated region by the mRNA endonuclease polysomal ribonuclease 1.

Authors:  K S Cunningham; R E Dodson; M A Nagel; D J Shapiro; D R Schoenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

3.  The role of 3'-untranslated region (3'-UTR) mediated mRNA stability in cardiovascular pathophysiology.

Authors:  C M Misquitta; V R Iyer; E S Werstiuk; A K Grover
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

4.  The poly(A)-binding protein and an mRNA stability protein jointly regulate an endoribonuclease activity.

Authors:  Z Wang; M Kiledjian
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

Review 5.  Novel endoribonucleases as central players in various pathways of eukaryotic RNA metabolism.

Authors:  Rafal Tomecki; Andrzej Dziembowski
Journal:  RNA       Date:  2010-07-30       Impact factor: 4.942

6.  Regulation of luteinizing hormone receptor mRNA expression by a specific RNA binding protein in the ovary.

Authors:  K M J Menon; Anil K Nair; Lei Wang; Helle Peegel
Journal:  Mol Cell Endocrinol       Date:  2006-10-19       Impact factor: 4.102

7.  RNA-binding protein insulin-like growth factor mRNA-binding protein 3 (IMP-3) promotes cell survival via insulin-like growth factor II signaling after ionizing radiation.

Authors:  Baisong Liao; Yan Hu; Gary Brewer
Journal:  J Biol Chem       Date:  2011-07-14       Impact factor: 5.157

8.  In vitro assembly of the mouse U14 snoRNP core complex and identification of a 65-kDa box C/D-binding protein.

Authors:  N J Watkins; D R Newman; J F Kuhn; E S Maxwell
Journal:  RNA       Date:  1998-05       Impact factor: 4.942

9.  Human La protein: a stabilizer of histone mRNA.

Authors:  R S McLaren; N Caruccio; J Ross
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

10.  RasGAP-associated endoribonuclease G3Bp: selective RNA degradation and phosphorylation-dependent localization.

Authors:  H Tourrière; I E Gallouzi; K Chebli; J P Capony; J Mouaikel; P van der Geer; J Tazi
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.